Literature DB >> 21168226

Emerging role for drug transporters at the blood-testis barrier.

Dolores D Mruk1, Linlin Su, C Yan Cheng.   

Abstract

Drug transporters are integral membrane proteins that transport a broad range of substrates into and out of cells, usually against a concentration gradient. Studies have shown that efflux pumps such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) localize at the blood-testis barrier (BTB), where they protect the testis from drugs and xenobiotics that are detrimental to spermatogenesis. At the same time, efflux pumps might also preclude entry of non-hormonal contraceptives to the testis. In more recent studies, P-gp function was correlated with BTB integrity. In this review, we discuss findings that have made a significant impact on our understanding of efflux pumps in the testis. Modulation of efflux pump function via specific inhibitors could help to deliver contraceptives to the testis in the future.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168226      PMCID: PMC3052295          DOI: 10.1016/j.tips.2010.11.007

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  81 in total

Review 1.  Impact of drug transporter studies on drug discovery and development.

Authors:  Naomi Mizuno; Takuro Niwa; Yoshihisa Yotsumoto; Yuichi Sugiyama
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

2.  Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier.

Authors:  Björn Bauer; Anika M S Hartz; Gert Fricker; David S Miller
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

3.  Regulation of the stability of P-glycoprotein by ubiquitination.

Authors:  Zhigang Zhang; Jin-Ying Wu; William N Hait; Jin-Ming Yang
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

Review 4.  Importance of P-glycoprotein at blood-tissue barriers.

Authors:  Martin F Fromm
Journal:  Trends Pharmacol Sci       Date:  2004-08       Impact factor: 14.819

5.  Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human.

Authors:  Nathalie Melaine; Marie-Odile Liénard; Isabelle Dorval; Claude Le Goascogne; Hervé Lejeune; Bernard Jégou
Journal:  Biol Reprod       Date:  2002-12       Impact factor: 4.285

Review 6.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

7.  The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours.

Authors:  J Bart; H Hollema; H J M Groen; E G E de Vries; N H Hendrikse; D T Sleijfer; T D Wegman; W Vaalburg; W T A van der Graaf
Journal:  Eur J Cancer       Date:  2004-09       Impact factor: 9.162

8.  Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.

Authors:  F Pizzagalli; B Hagenbuch; B Stieger; U Klenk; G Folkers; P J Meier
Journal:  Mol Endocrinol       Date:  2002-10

9.  Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.

Authors:  Gigi Lee; Micheline Piquette-Miller
Journal:  J Pharm Sci       Date:  2003-11       Impact factor: 3.534

10.  P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.

Authors:  Julie Jodoin; Michel Demeule; Laurence Fenart; Roméo Cecchelli; Sarah Farmer; Kenneth J Linton; Christopher F Higgins; Richard Béliveau
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

View more
  34 in total

Review 1.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

2.  F5-peptide enhances the efficacy of the non-hormonal male contraceptive adjudin.

Authors:  Haiqi Chen; Dolores Mruk; Chris K C Wong; Bruno Silvestrini; C Yan Cheng
Journal:  Contraception       Date:  2019-02-11       Impact factor: 3.375

Review 3.  Breast cancer resistance protein (Bcrp) and the testis--an unexpected turn of events.

Authors:  Xiaojing Qian; Yan-Ho Cheng; Dolores D Mruk; C Yan Cheng
Journal:  Asian J Androl       Date:  2013-05-13       Impact factor: 3.285

4.  F5-Peptide and mTORC1/rpS6 Effectively Enhance BTB Transport Function in the Testis-Lesson From the Adjudin Model.

Authors:  Baiping Mao; Linxi Li; Ming Yan; Chris K C Wong; Bruno Silvestrini; Chao Li; Renshan Ge; Qingquan Lian; C Yan Cheng
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

Review 5.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

Review 6.  Interaction of oligomeric breast cancer resistant protein (BCRP) with adjudin: a male contraceptive with anti-cancer activity.

Authors:  Yan Ho Cheng; Pranitha Jenardhanan; Premendu P Mathur; Xiaojing Qian; Weiliang Xia; Bruno Silvestrini; Chuen Yan Cheng
Journal:  Curr Mol Pharmacol       Date:  2014       Impact factor: 3.339

Review 7.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

Review 8.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

Review 9.  Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.

Authors:  Joana Bicker; Gilberto Alves; Amílcar Falcão; Ana Fortuna
Journal:  Br J Pharmacol       Date:  2020-03-20       Impact factor: 8.739

Review 10.  Sertoli cells are the target of environmental toxicants in the testis - a mechanistic and therapeutic insight.

Authors:  Ying Gao; Dolores D Mruk; C Yan Cheng
Journal:  Expert Opin Ther Targets       Date:  2015-04-26       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.